Streamline Health Solutions (STRM) Stock Price

Streamline Health Solutions Price

NASDAQ·CLOSED
5.33
​
Market closed

Revenue has compounded at 0.5% per year over the past 19 years to 17.90 M USD. Earnings per share have declined at 19.8% per year over the last 15 years. Streamline Health Solutions's net margin stands at -56.8%, down from 2.6% several years earlier. Analysts set a median price target of 1.53 USD, implying 71.3% below the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

Streamline Health Solutions stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Streamline Health Solutions business model & stock analysis

Streamline Health Solutions Inc generates revenue through its Looking Glass platform, offering software-based solutions for healthcare organizations. The company sells these solutions and implementation services directly to hospitals and health systems in North America, including physician practices, via its direct sales force and reseller partnerships. Its software enables healthcare providers in the U.S. and Canada to manage clinical, financial, and other patient information effectively. The firm's primary customers are hospitals and integrated healthcare delivery systems across the United States and Canada, purchasing both the Looking Glass platform and complementary consulting services. Revenue streams include software licensing, implementation support, and ongoing consulting engagements tailored to healthcare data management needs. Streamline Health Solutions Inc's business model focuses on delivering transformational data-driven solutions through its proprietary Looking Glass platform, with a strong emphasis on serving healthcare organizations requiring efficient data processing and management capabilities.

Frequently asked questions about Streamline Health Solutions

Analysts currently set an average price target of 1.53 USD for the Streamline Health Solutions stock (median: 1.53 USD), implying -71.3 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Streamline Health Solutions stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Streamline Health Solutions to generate revenue of 21.24 M USD and earnings per share of -0.12 USD.

Converted at the current exchange rate, the Streamline Health Solutions share trades at 4.78 EUR (5.33 USD).

The Streamline Health Solutions share (STRM) is listed on 2 stock exchanges, including: NASDAQ (STRM), Frankfurt (LV1.F).

The expected revenue of Streamline Health Solutions is 21.24 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Streamline Health Solutions is -489,192.00 USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Streamline Health Solutions is currently -43.71. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Streamline Health Solutions stock.

The price-to-sales ratio (P/S) of Streamline Health Solutions is currently 1.01. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Streamline Health Solutions stock.

The Eulerpool Quality Score for Streamline Health Solutions is 2/10.

The ISIN of Streamline Health Solutions is US86323X2053. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Streamline Health Solutions is A0J3YQ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Streamline Health Solutions is STRM. The ticker symbol is used to trade Streamline Health Solutions shares on the stock exchange.

Fair ValueTerminal
5.39 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
223,762.50 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Apr 18, 1996
ISIN
US86323X2053
Cusip
86323X106
Sedol
2503790
Market capitalization
23.25 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-43.71
P/S
P/Se
1.01
EV/EBIT
—
P/B Ratio
1.89
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-39.99 %
Last updated Nov 2, 2026, 5:17 PM

Streamline Health Solutions Ticker

FRANKFURT · LV1.FNASDAQ · STRM

All fundamentals and in-depth analysis of Streamline Health Solutions

Our stock analysis for Streamline Health Solutions stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Streamline Health Solutions. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.